Balance Sheet Breakdown: Bausch Health Companies Inc (BHC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $8.08 in the prior trading day, Bausch Health Companies Inc (NYSE: BHC) closed at $8.03, down -0.62%. In other words, the price has decreased by -$0.62 from its previous closing price. On the day, 1.85 million shares were traded. BHC stock price reached its highest trading level at $8.1 during the session, while it also had its lowest trading level at $7.935.

Ratios:

Our goal is to gain a better understanding of BHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.23. For the most recent quarter (mrq), Quick Ratio is recorded 0.82 and its Current Ratio is at 1.19.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.

On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.

Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 06 ’24 when Carson Seana sold 13,370 shares for $6.21 per share. The transaction valued at 83,028 led to the insider holds 435,198 shares of the business.

Carson Seana bought 13,370 shares of BHC for $83,028 on Sep 06 ’24. On Mar 04 ’24, another insider, Carson Seana, who serves as the EVP, General Counsel of the company, sold 6,313 shares for $9.80 each. As a result, the insider received 61,867 and left with 499,905 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2962026240 and an Enterprise Value of 24960835584. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.32. Its current Enterprise Value per Revenue stands at 2.713 whereas that against EBITDA is 8.323.

Stock Price History:

Over the past 52 weeks, BHC has reached a high of $11.46, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is 26.82%, while the 200-Day Moving Average is calculated to be 5.73%.

Shares Statistics:

The stock has traded on average 3.79M shares per day over the past 3-months and 3188290 shares per day over the last 10 days, according to various share statistics. A total of 365.24M shares are outstanding, with a floating share count of 320.79M. Insiders hold about 12.61% of the company’s shares, while institutions hold 76.81% stake in the company. Shares short for BHC as of 1724976000 were 19829290 with a Short Ratio of 5.24, compared to 1722384000 on 19719345. Therefore, it implies a Short% of Shares Outstanding of 19829290 and a Short% of Float of 5.84.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 6.52.

Most Popular